RNA Biomarkers as a Response Measure for Survival in Patients with Metastatic Castration-Resistant Prostate Cancer.

Cancers (Basel) · 2021 · PMC8699291 · PMID 34944897

Europe PMC DOI

hedged sentence

0.0880

closest p · 1.8× alpha

0.0880

boldest claim

The sentences

showed a trendp = 0.088so close (0.05 < p ≤ 0.1)

For NAALADL2-AS2 a low expression at baseline showed a trend for shorter OS compared to a high expression, median time to OS 21.9 months (95% CI; 18.8–44.9) vs. 30.7 (95% CI; 27.6–43.4) ( p = 0.088) ( Figure 3 D). 3.2.4.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.